Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
about
Hydrodynamic modulation of pluripotent stem cellsOptimizing Stem Cells Mobilization Strategies to Ameliorate Patient Outcomes: A Review of Guide- lines and Recommendations.Epidemiology Investigation of stroke among Mongolian and Han population aged over 45 in Inner Mongolia.Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma.Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma.The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies.Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.How do we mobilize and collect autologous peripheral blood stem cells?Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose.Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AMLNotch2 blockade enhances hematopoietic stem cell mobilization and homing.Blood graft composition after plerixafor injection in patients with NHL.Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34(+) cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers.Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas.Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study.Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.An algorithm for utilizing peripheral blood CD34 count as a predictor of the need for plerixafor in autologous stem cell mobilization--cost-effectiveness analysis.
P2860
Q36633029-A2F19C5C-C1E6-46E2-8B1D-DD242444F167Q37682128-AEA11144-79B7-4A06-AF70-66ED6DE32F6DQ37736677-F6B566AC-4114-4865-9D73-891A31A10E2CQ37921284-8205B726-511D-4FF6-BE80-C3E3D734E2CCQ38160461-2CF21B64-E92B-4C61-A9BA-468A086445E8Q38256923-8D9EC5BD-BD53-4FCF-B50D-3BD32928E7DDQ38349208-D2AC7100-5C38-475D-BCD6-35ED2919195CQ38978669-844588C6-6E72-4BB5-B94D-2DA56C85FB77Q40490106-2C7C44A0-2170-4FB8-B4AB-E585FD00EBF3Q40563007-390F57DD-B037-47DC-904B-42180603D622Q41092832-9E58EDA6-F557-4FC0-A421-13F087D61A68Q42106581-FE85D628-F2EC-4F68-B809-F66747BC5E4DQ42368326-ACE43DE3-053E-4C78-B879-24CE5DCF9E83Q44353274-929659D6-F087-4F25-AD25-DAC86BFC15C6Q46829929-02C4672C-9B0B-4D04-9959-E075B7A6D17EQ48097743-74895A5D-5B37-40EE-AFCB-B8922ECAE849Q48251610-0892F665-49A1-4835-9E91-A654BA774E57Q49487144-538745ED-B851-4D8E-AAC9-23F08C63B550Q50690379-7CE054DA-52F4-411E-8950-16A6C1F7611CQ51253946-A5CA64A9-C05F-4287-BC30-8F906516E5DB
P2860
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Transplanted CD34
@nl
Transplanted CD34(+) cell dose ...... lymphoma or multiple myeloma.
@en
type
label
Transplanted CD34
@nl
Transplanted CD34(+) cell dose ...... lymphoma or multiple myeloma.
@en
prefLabel
Transplanted CD34
@nl
Transplanted CD34(+) cell dose ...... lymphoma or multiple myeloma.
@en
P2093
P1476
Transplanted CD34(+) cell dose ...... lymphoma or multiple myeloma.
@en
P2093
Auayporn P Nademanee
Brian J Bolwell
Edward A Stadtmauer
Frank J Hsu
Gary Bridger
Ivana Micallef
John F DiPersio
Patrick J Stiff
Richard T Maziarz
Sachin Marulkar
P304
P356
10.1016/J.BBMT.2010.11.021
P577
2010-11-30T00:00:00Z